The estimated Net Worth of Capital Management, Llcra C... is at least $61.7 Milion dollars as of 12 November 2008. Capital C owns over 48,465 units of Biospecifics Technologies stock worth over $61,732,766 and over the last 16 years Capital sold BSTC stock worth over $0.
Capital has made over 3 trades of the Biospecifics Technologies stock since 2008, according to the Form 4 filled with the SEC. Most recently Capital bought 48,465 units of BSTC stock worth $793,857 on 12 November 2008.
The largest trade Capital's ever made was buying 48,465 units of Biospecifics Technologies stock on 12 November 2008 worth over $793,857. On average, Capital trades about 20,288 units every 4 days since 2008. As of 12 November 2008 Capital still owns at least 697,309 units of Biospecifics Technologies stock.
You can see the complete history of Capital C stock trades at the bottom of the page.
Over the last 33 years, insiders at Biospecifics Technologies have traded over $67,860,045 worth of Biospecifics Technologies stock and bought 7,761,661 units worth $656,708,120 . The most active insiders traders include Capital Management, Llc Kol..., International Plc Endo a Max Link. On average, Biospecifics Technologies executives and independent directors trade stock every 73 days with the average trade being worth of $6,538,649. The most recent stock trade was executed by International Plc Endo on 2 December 2020, trading 7,344,955 units of BSTC stock currently worth $650,028,518.
Biospecifics Technologies executives and other stock owners filed with the SEC include: